| pubmed-article:20879879 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20879879 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
| pubmed-article:20879879 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:20879879 | lifeskim:mentions | umls-concept:C1335892 | lld:lifeskim |
| pubmed-article:20879879 | lifeskim:mentions | umls-concept:C1999216 | lld:lifeskim |
| pubmed-article:20879879 | pubmed:issue | 14 | lld:pubmed |
| pubmed-article:20879879 | pubmed:dateCreated | 2010-9-30 | lld:pubmed |
| pubmed-article:20879879 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20879879 | pubmed:abstractText | Spleen tyrosine kinase (Syk) is an important modulator of immune signaling. The objective of this phase 2 study was to evaluate the efficacy and safety of R788, an oral inhibitor of Syk, in patients with active rheumatoid arthritis despite methotrexate therapy. | lld:pubmed |
| pubmed-article:20879879 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20879879 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20879879 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20879879 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20879879 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20879879 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20879879 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20879879 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:20879879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20879879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20879879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20879879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20879879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20879879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20879879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20879879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20879879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20879879 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20879879 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:20879879 | pubmed:issn | 1533-4406 | lld:pubmed |
| pubmed-article:20879879 | pubmed:author | pubmed-author:GenoveseMark... | lld:pubmed |
| pubmed-article:20879879 | pubmed:author | pubmed-author:WeinblattMich... | lld:pubmed |
| pubmed-article:20879879 | pubmed:author | pubmed-author:KavanaughArth... | lld:pubmed |
| pubmed-article:20879879 | pubmed:author | pubmed-author:GrossbardElli... | lld:pubmed |
| pubmed-article:20879879 | pubmed:author | pubmed-author:MagilavyDanie... | lld:pubmed |
| pubmed-article:20879879 | pubmed:author | pubmed-author:MusserTheresa... | lld:pubmed |
| pubmed-article:20879879 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20879879 | pubmed:day | 30 | lld:pubmed |
| pubmed-article:20879879 | pubmed:volume | 363 | lld:pubmed |
| pubmed-article:20879879 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20879879 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20879879 | pubmed:pagination | 1303-12 | lld:pubmed |
| pubmed-article:20879879 | pubmed:dateRevised | 2011-11-2 | lld:pubmed |
| pubmed-article:20879879 | pubmed:meshHeading | pubmed-meshheading:20879879... | lld:pubmed |
| pubmed-article:20879879 | pubmed:meshHeading | pubmed-meshheading:20879879... | lld:pubmed |
| pubmed-article:20879879 | pubmed:meshHeading | pubmed-meshheading:20879879... | lld:pubmed |
| pubmed-article:20879879 | pubmed:meshHeading | pubmed-meshheading:20879879... | lld:pubmed |
| pubmed-article:20879879 | pubmed:meshHeading | pubmed-meshheading:20879879... | lld:pubmed |
| pubmed-article:20879879 | pubmed:meshHeading | pubmed-meshheading:20879879... | lld:pubmed |
| pubmed-article:20879879 | pubmed:meshHeading | pubmed-meshheading:20879879... | lld:pubmed |
| pubmed-article:20879879 | pubmed:meshHeading | pubmed-meshheading:20879879... | lld:pubmed |
| pubmed-article:20879879 | pubmed:meshHeading | pubmed-meshheading:20879879... | lld:pubmed |
| pubmed-article:20879879 | pubmed:meshHeading | pubmed-meshheading:20879879... | lld:pubmed |
| pubmed-article:20879879 | pubmed:meshHeading | pubmed-meshheading:20879879... | lld:pubmed |
| pubmed-article:20879879 | pubmed:meshHeading | pubmed-meshheading:20879879... | lld:pubmed |
| pubmed-article:20879879 | pubmed:meshHeading | pubmed-meshheading:20879879... | lld:pubmed |
| pubmed-article:20879879 | pubmed:meshHeading | pubmed-meshheading:20879879... | lld:pubmed |
| pubmed-article:20879879 | pubmed:meshHeading | pubmed-meshheading:20879879... | lld:pubmed |
| pubmed-article:20879879 | pubmed:meshHeading | pubmed-meshheading:20879879... | lld:pubmed |
| pubmed-article:20879879 | pubmed:meshHeading | pubmed-meshheading:20879879... | lld:pubmed |
| pubmed-article:20879879 | pubmed:meshHeading | pubmed-meshheading:20879879... | lld:pubmed |
| pubmed-article:20879879 | pubmed:meshHeading | pubmed-meshheading:20879879... | lld:pubmed |
| pubmed-article:20879879 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20879879 | pubmed:articleTitle | An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis. | lld:pubmed |
| pubmed-article:20879879 | pubmed:affiliation | Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. mweinblatt@partners.org | lld:pubmed |
| pubmed-article:20879879 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20879879 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:20879879 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:20879879 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:20879879 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20879879 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20879879 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20879879 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20879879 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20879879 | lld:pubmed |
